Coronaviruses are a priority for NIAID. Three forms have emerged over the past two decades. These cause the serious and widespread diseases SARS, MERS, and COVID-19.

NIAID scientists and NIAID-supported researchers continue to conduct basic, translational and clinical research aimed at identifying effective therapeutics for early COVID-19 infection and …

Feb 2, 2022 · As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing …

Mar 17, 2021 · COVID-19 is a once-in-a-lifetime global infectious disease pandemic requiring an unprecedented public-private research effort. NIAID plays a central and important role in the …

Apr 23, 2020 · A new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, details the institute’s plan for accelerating …

Jun 16, 2022 · NIAID has played a central role in this response by capitalizing on decades of basic, clinical, and applied research to facilitate the rapid development of COVID-19 vaccines, …

NIAID also works closely with partners in academia, industry, government, and non-governmental organizations in multifaceted and multidisciplinary efforts to address emerging health …

On April 29, the National Institute of Health disclosed the preliminary findings of the ACTT-1 (Adaptive COVID-19 Treatment Trial) (NCT04280705), the first clinical trial in the United …

Aug 2, 2023 · Dr. Jeanne Marrazzo has been selected as the next director of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health announced in a news …

6 days ago · Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the …